Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Lindsey Rolfe. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Lindsey Rolfe har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CLVS / Clovis Oncology Inc See Remarks 113.691
US:BCEL / Atreca, Inc. Director 12.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Lindsey Rolfe. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Lindsey Rolfe som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.353 113.691 -2,03 0,98 -2.313 111.747
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.908 111.419 -1,68 0,98 -1.875 109.514
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 116.044 4,15
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 113.327 3,42
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.545 109.578 -2,27 1,20 -3.054 131.494
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.063 112.123 4,73
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.391 107.060 -2,18 1,46 -3.493 156.404
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.939 104.826 -1,82 1,46 -2.833 153.140
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 109.451 4,41
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 106.765 3,64
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.650 103.016 -2,51 0,64 -1.703 66.188
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5.062 105.666 5,03
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.348 100.604 -2,28 1,97 -4.625 198.170
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.904 98.327 -1,90 1,97 -3.750 193.685
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 32.375 -12,50
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 11.248 -25,00
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 102.952 4,70
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 100.231 3,89
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -10.585 96.482 -9,89 1,87 -19.752 180.035
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -360 86.817 -0,41 1,87 -672 162.001
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 0 -100,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 20.250 60.750 50,00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81.000 81.000
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 20.250 107.067 23,32
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 87.177 0,80
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.493 86.489 -2,80 1,94 -4.836 167.763
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.021 84.357 -2,34 1,94 -3.920 163.619
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 37.000 -11,11
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.750 14.997 -20,00
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 88.982 5,48
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.750 86.378 4,54
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -346 82.628 -0,42 3,00 -1.038 247.884
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 688 -49,96
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 82.974 0,83
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.325 82.287 -2,75 4,55 -10.579 374.406
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.884 79.987 -2,30 4,55 -8.572 363.941
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 41.625 -10,00
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 18.747 -16,67
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 84.612 5,78
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 81.871 4,80
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -347 78.122 -0,44 4,89 -1.697 382.017
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 1.375 -33,35
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 78.469 0,88
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.317 77.781 -2,89 4,82 -11.168 374.904
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.878 75.473 -2,43 4,82 -9.052 363.780
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 46.250 -9,09
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 22.496 -14,28
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 80.098 6,13
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 77.351 5,09
2021-06-11 2021-06-09 4 BCEL Atreca, Inc.
Stock Option (right to buy)
A - Award 12.000 12.000
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -322 73.602 -0,44 5,63 -1.813 414.379
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 687 2.063 49,93
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 73.924 0,94
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.486 73.237 -3,28 5,54 -13.772 405.733
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.015 71.098 -2,76 5,54 -11.163 393.883
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4.625 50.875 -8,33
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 26.245 -12,50
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.625 75.723 6,51
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 73.113 5,40
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -346 69.364 -0,50 6,29 -2.176 436.300
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -315 69.022 -0,45 6,29 -1.981 434.148
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 2.750 33,37
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 625 0 -100,00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81.000 81.000
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 69.710 1,00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 69.337 0,91
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9.822 68.712 -12,51 7,97 -78.281 547.635
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.991 60.034 -3,21 7,97 -15.868 478.471
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -18.500 55.500 -25,00
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.750 29.994 -11,11
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18.500 78.534 30,82
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.750 62.025 6,44
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 0 -100,00
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 58.275 -2,88 5,68 -9.815 331.002
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 60.003 6,08
2020-12-16 2020-12-15 4 CLVS Clovis Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise -17.241 0 -100,00
2020-12-16 2020-12-15 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -14.153 56.565 -20,01 5,11 -72.322 289.047
2020-12-16 2020-12-15 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 17.241 70.718 32,24 3,28 56.550 231.955
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 3.438 -16,65
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 625 -50,00
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -346 53.477 -0,64 4,89 -1.692 261.503
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 53.823 1,29
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -315 53.136 -0,59 4,89 -1.540 259.835
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 53.451 1,18
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 33.744 -10,00
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.920 52.826 -3,51 4,93 -9.466 260.432
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 54.746 7,35
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 3.438 -49,99
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.726 50.997 -3,27 6,85 -11.823 349.329
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -21 52.723 -0,04 6,86 -144 361.680
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 52.744 6,97
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 4.125 -14,29
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 1.250 -33,33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -329 49.307 -0,66 5,30 -1.744 261.327
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 49.636 1,41
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -299 48.948 -0,61 5,30 -1.585 259.424
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 49.247 1,29
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 37.493 -9,09
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.899 48.622 -3,76 5,92 -11.242 287.842
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 50.521 8,02
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 6.875 -33,34
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 46.772 -3,56 6,74 -11.647 315.243
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 48.500 7,63
2020-06-15 2020-06-10 4 BCEL Atreca, Inc.
Stock Option (right to buy)
A - Award 12.000 12.000
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 4.813 -12,49
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 1.875 -25,00
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -356 45.062 -0,78 7,03 -2.503 316.786
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 45.418 1,54
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -324 44.731 -0,72 7,03 -2.278 314.459
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 45.055 1,41
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.749 41.242 -8,33
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.677 44.430 -3,64 8,10 -13.584 359.883
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.749 46.107 8,85
2020-04-08 2020-04-06 4 CLVS Clovis Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise -23.034 0 -100,00
2020-04-08 2020-04-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -16.733 42.358 -28,32 6,80 -113.784 288.034
2020-04-08 2020-04-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 23.034 59.091 63,88 3,08 70.945 182.000
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 10.313 -25,00
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 36.057 -4,57 4,60 -7.949 165.862
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 37.785 10,01
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 5.500 -11,12
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 2.500 -20,00
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -360 34.348 -1,04 7,20 -2.592 247.306
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 34.708 2,02
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -327 34.020 -0,95 7,20 -2.354 244.944
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 34.347 1,85
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -14.997 44.991 -25,00
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7.503 33.722 -18,20 8,41 -63.100 283.602
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 14.997 41.225 57,18
2020-01-31 2020-01-31 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 74.000 74.000
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 13.750 -20,00
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.729 26.228 -6,18 11,30 -19.538 296.376
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 27.957 14,02
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 6.188 -9,99
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 3.125 -16,67
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -353 24.519 -1,42 14,61 -5.157 358.223
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 24.872 2,84
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -321 24.185 -1,31 14,59 -4.683 352.859
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 24.506 2,62
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 17.188 -16,66
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.744 23.881 -6,81 4,80 -8.371 114.629
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 25.625 15,49
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 6.875 -9,10
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 3.750 -14,29
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -375 22.188 -1,66 5,21 -1.954 115.599
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 22.563 3,15
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -341 21.875 -1,53 5,21 -1.777 113.969
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 22.216 2,89
2019-08-22 2019-08-22 4 BCEL Atreca, Inc.
Stock Option (right to buy)
A - Award 24.000 24.000
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 20.625 -14,29
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 21.591 -7,41 14,70 -25.402 317.388
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 23.319 17,29
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 7.563 -8,33
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 4.375 -12,50
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -343 19.881 -1,70 15,07 -5.169 299.607
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 20.224 3,52
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -312 19.537 -1,57 15,07 -4.702 294.423
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 19.849 3,25
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 24.063 -12,50
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.729 19.224 -8,25 26,13 -45.179 502.323
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 20.953 19,62
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2.750 8.250 -25,00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 5.000 -11,11
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.410 17.516 -7,45 29,29 -41.299 513.044
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.750 18.926 17,00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -321 16.176 -1,95 29,29 -9.402 473.795
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 16.497 3,94
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 59.988 59.988
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 19.996 19.996
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 27.500 -11,11
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.728 15.872 -9,82 17,72 -30.620 281.252
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 17.600 24,28
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 5.625 -10,00
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -284 14.162 -1,97 21,23 -6.029 300.659
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 14.446 4,52
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 30.938 -10,00
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1.728 13.821 -11,11 32,21 -55.659 445.174
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 15.549 28,38
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 6.250 -9,09
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -321 12.112 -2,58 35,75 -11.476 433.004
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 12.433 5,29
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.438 34.375 -9,09
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1.728 11.808 -12,77 45,75 -79.056 540.216
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.438 13.536 34,05
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 6.875 -8,33
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -316 10.098 -3,03 47,70 -15.073 481.675
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 10.414 6,38
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3.437 37.813 -8,33
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1.728 9.789 -15,00 56,75 -98.064 555.526
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3.437 11.517 42,54
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2.500 7.500 -25,00
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1.260 8.080 -13,49 58,43 -73.622 472.114
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2.500 9.340 36,55
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 11.000 11.000
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 11.000 11.000
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -13.750 41.250 -25,00
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -6.910 6.840 -50,25 63,80 -440.858 436.392
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 13.750 13.750
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 10.000 10.000
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 20.000 20.000
2016-12-19 2016-12-19 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 55.000 55.000
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Employee stock option (right to buy)
M - Exercise -4.000 23.034 -14,80
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -238 0 -100,00 99,22 -23.614
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.962 238 -89,18 98,91 -194.054 23.540
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.300 2.200 -37,14 97,31 -126.507 214.089
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -500 3.500 -12,50 95,78 -47.890 335.226
2015-10-30 2015-10-28 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.000 4.000 3,08 12.320 12.320
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Employee stock option (right to buy)
M - Exercise -4.000 27.034 -12,89
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -322 0 -100,00 96,13 -30.953
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -400 322 -55,40 93,92 -37.570 30.244
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.221 722 -75,47 93,01 -206.566 67.150
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.057 2.943 -26,42 91,84 -97.071 270.273
2015-10-07 2015-10-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4.000 4.000 3,08 12.320 12.320
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)